{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:56Z","timestamp":1740149876379,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2020QNB045"],"award-info":[{"award-number":["2020QNB045"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018623","name":"Quanzhou City Science and Technology Program","doi-asserted-by":"publisher","award":["2023NS068"],"award-info":[{"award-number":["2023NS068"]}],"id":[{"id":"10.13039\/501100018623","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project on the Integration of Industry, Education and Research Collaborative Innovation of Fujian Province","award":["2021YZ034011"],"award-info":[{"award-number":["2021YZ034011"]}]},{"name":"Key Project on Science and Technology Program of Fujian Health Commission","award":["2021ZD01002"],"award-info":[{"award-number":["2021ZD01002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Isolated terminal 4q35.2 microdeletion is an extremely rare copy number variant affecting people all over the world. To date, researchers still have controversial opinions and results on its pathogenicity. Here, we aim to present a Chinese pediatric patient with terminal 4q35.2 microdeletion and use this case to clarify the underlying genotype\u2013phenotype correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A 17-year-old boy from Quanzhou, South China, was recruited as the main subject in this study. Karyotype and single-nucleotide polymorphism (SNP) based microarray analysis were carried out to detect chromosomal abnormalities and copy number variants in this family. Trio whole exome sequencing (Trio-WES) was performed to investigate the potential pathogenic variant in this family.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During observation, we identified abnormal clinical phenotypes including\u00a0upper eyelid ptosis, motor developmental delay, abnormal posturing, abnormality of coordination, attention deficit hyperactivity disorder, and involuntary movements in the patient. SNP array analysis results confirmed a case of 2.0 Mb 4q35.2 microdeletion and parental SNP array verification results indicated that the terminal 4q35.2 microdeletion was inherited from his mother. No copy number variants were detected in his father. In addition, the trio-WES results demonstrated none of pathogenic or likely pathogenic variants in the patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study brings a novel analysis of a case of 2.0 Mb terminal 4q35.2 microdeletion affecting a Chinese individual. In addition, additional clinical symptoms such as upper eyelid ptosis and involuntary movements were first reported to affect a patient with terminal 4q35.2 microdeletion, which may broaden the phenotype spectrum of the condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13039-023-00651-3","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:01:34Z","timestamp":1690977694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of a novel isolated 4q35.2 microdeletion in a Chinese pediatric patient using chromosomal microarray analysis: a case report and literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Jianlong","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunnuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"6","key":"651_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/pd.3866","volume":"32","author":"JK Morris","year":"2012","unstructured":"Morris JK, Waters JJ, de Souza E. The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008. Prenat Diagn. 2012;32(6):596\u2013601.","journal-title":"Prenat Diagn"},{"issue":"5","key":"651_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","volume":"86","author":"DT Miller","year":"2010","unstructured":"Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749\u201364.","journal-title":"Am J Hum Genet"},{"key":"651_CR3","doi-asserted-by":"crossref","unstructured":"Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Dugoff L, Norton ME, Kuller JA. The use of chromosomal microarray for\u00a0prenatal\u00a0diagnosis [published correction appears in Am J Obstet Gynecol. 2017 Feb;216(2):180].\u00a0Am J Obstet Gynecol. 2016;215(4):B2-B9","DOI":"10.1016\/j.ajog.2016.07.016"},{"key":"651_CR4","doi-asserted-by":"publisher","first-page":"9352581","DOI":"10.1155\/2019\/9352581","volume":"2019","author":"T Hu","year":"2019","unstructured":"Hu T, Zhang Z, Wang J, et al. Chromosomal aberrations in pediatric patients with developmental delay\/intellectual disability: a single-center clinical investigation. Biomed Res Int. 2019;2019:9352581.","journal-title":"Biomed Res Int"},{"issue":"3","key":"651_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3343\/alm.2019.39.3.299","volume":"39","author":"W Jang","year":"2019","unstructured":"Jang W, Kim Y, Han E, et al. Chromosomal microarray analysis as a first-tier clinical diagnostic test in patients with developmental delay\/intellectual disability, autism spectrum disorders, and multiple congenital anomalies: a prospective multicenter study in Korea. Ann Lab Med. 2019;39(3):299\u2013310.","journal-title":"Ann Lab Med"},{"key":"651_CR6","doi-asserted-by":"publisher","first-page":"798607","DOI":"10.3389\/fgene.2022.798607","volume":"13","author":"P Granata","year":"2022","unstructured":"Granata P, Cocciadiferro D, Zito A, et al. Whole exome sequencing in 16p13.11 microdeletion patients reveals new variants through deductive and systems medicine approaches. Front Genet. 2022;13:798607.","journal-title":"Front Genet"},{"issue":"2","key":"651_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejmg.2018.06.010","volume":"62","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Bagheri H, Tang F, et al. Exome sequencing identified a de novo mutation of PURA gene in a patient with familial Xp22.31 microduplication. Eur J Med Genet. 2019;62(2):103\u20138.","journal-title":"Eur J Med Genet"},{"issue":"3","key":"651_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/0019-5154.96203","volume":"57","author":"CM Kuldeep","year":"2012","unstructured":"Kuldeep CM, Khare AK, Garg A, Mittal A, Gupta L. Terminal 4q deletion syndrome. Indian J Dermatol. 2012;57(3):222\u20134.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"651_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.gene.2012.06.087","volume":"506","author":"EM Strehle","year":"2012","unstructured":"Strehle EM, Gruszfeld D, Schenk D, Mehta SG, Simonic I, Huang T. The spectrum of 4q- syndrome illustrated by a case series. Gene. 2012;506(2):387\u201391.","journal-title":"Gene"},{"issue":"2","key":"651_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/1096-8628(2000)9999:999<00::AID-AJMG1134>3.0.CO;2-D","volume":"99","author":"SL Keeling","year":"2001","unstructured":"Keeling SL, Lee-Jones L, Thompson P. Interstitial deletion 4q32-34 with ulnar deficiency: 4q33 may be the critical region in 4q terminal deletion syndrome. Am J Med Genet. 2001;99(2):94\u20138.","journal-title":"Am J Med Genet"},{"issue":"1","key":"651_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000442068","volume":"147","author":"F Riccardi","year":"2015","unstructured":"Riccardi F, Rivolta GF, Uliana V, et al. Cryptic 13q34 and 4q35.2 deletions in an Italian family. Cytogenet Genome Res. 2015;147(1):24\u201330.","journal-title":"Cytogenet Genome Res"},{"issue":"3\u20134","key":"651_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000515368","volume":"161","author":"T Karaman Mercan","year":"2021","unstructured":"Karaman Mercan T, Altiok Clark O, Erkal O, et al. Coexistence of a homozygous chromosome 4q35.2 deletion and Hidden IQSEC2 pathogenic variant in a child with intellectual disability. Cytogenet Genome Res. 2021;161(3\u20134):153\u20139.","journal-title":"Cytogenet Genome Res"},{"issue":"11","key":"651_CR13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00431-011-1533-3","volume":"170","author":"G Cuturilo","year":"2011","unstructured":"Cuturilo G, Menten B, Krstic A, et al. 4q34.1-q35.2 deletion in a boy with phenotype resembling 22q11.2 deletion syndrome. Eur J Pediatr. 2011;170(11):1465\u201370.","journal-title":"Eur J Pediatr"},{"key":"651_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2350-5-21","volume":"5","author":"BS Pickard","year":"2004","unstructured":"Pickard BS, Hollox EJ, Malloy MP, et al. A 4q35.2 subtelomeric deletion identified in a screen of patients with co-morbid psychiatric illness and mental retardation. BMC Med Genet. 2004;5:21.","journal-title":"BMC Med Genet"},{"issue":"12","key":"651_CR15","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/ajmg.a.33088","volume":"149A","author":"MR Rossi","year":"2009","unstructured":"Rossi MR, DiMaio MS, Xiang B, et al. Clinical and genomic characterization of distal duplications and deletions of chromosome 4q: study of two cases and review of the literature. Am J Med Genet A. 2009;149A(12):2788\u201394.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"651_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/MCD.0b013e32834e9216","volume":"21","author":"EL Youngs","year":"2012","unstructured":"Youngs EL, Henkhaus RS, Hellings JA, Butler MG. 12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes. Clin Dysmorphol. 2012;21(2):93\u20136.","journal-title":"Clin Dysmorphol"},{"issue":"10","key":"651_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/humu.20537","volume":"28","author":"I Balikova","year":"2007","unstructured":"Balikova I, Menten B, de Ravel T, et al. Subtelomeric imbalances in phenotypically normal individuals. Hum Mutat. 2007;28(10):958\u201367.","journal-title":"Hum Mutat"},{"issue":"10","key":"651_CR18","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/ndt\/gfv465","volume":"31","author":"F Fu","year":"2016","unstructured":"Fu F, Chen F, Li R, et al. Prenatal diagnosis of fetal multicystic dysplastic kidney via high-resolution whole-genome array. Nephrol Dial Transplant. 2016;31(10):1693\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"651_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13039-021-00573-y","volume":"14","author":"G Xiao","year":"2021","unstructured":"Xiao G, Qiu X, Zhou Y, Tan G, Shen Y. Prenatal diagnosis of a 45-Mb deletion at chromosome 4q35.1q35.2: case report and literature review. Mol Cytogenet. 2021;14(1):53.","journal-title":"Mol Cytogenet"},{"key":"651_CR20","volume":"2013","author":"H Akbas","year":"2013","unstructured":"Akbas H, Cine N, Erdemoglu M, et al. Prenatal diagnosis of 4p and 4q subtelomeric microdeletion in de novo ring chromosome 4. Case Rep Obstet Gynecol. 2013;2013: 248050.","journal-title":"Case Rep Obstet Gynecol"},{"issue":"8","key":"651_CR21","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/ajmg.a.37097","volume":"167A","author":"S Yakut","year":"2015","unstructured":"Yakut S, Clarck OA, Sanhal C, et al. A familial interstitial 4q35 deletion with no discernible clinical effects. Am J Med Genet A. 2015;167A(8):1836\u201341.","journal-title":"Am J Med Genet A"},{"issue":"7079","key":"651_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature04422","volume":"439","author":"D Gabellini","year":"2006","unstructured":"Gabellini D, D\u2019Antona G, Moggio M, et al. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature. 2006;439(7079):973\u20137.","journal-title":"Nature"},{"issue":"3","key":"651_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0092-8674(02)00826-7","volume":"110","author":"D Gabellini","year":"2002","unstructured":"Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell. 2002;110(3):339\u201348.","journal-title":"Cell"},{"issue":"1","key":"651_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-021-01760-1","volume":"16","author":"T Sch\u00e4tzl","year":"2021","unstructured":"Sch\u00e4tzl T, Kaiser L, Deigner HP. Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update. Orphanet J Rare Dis. 2021;16(1):129.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"651_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","volume":"77","author":"M Zatz","year":"1998","unstructured":"Zatz M, Marie SK, Cerqueira A, Vainzof M, Pavanello RC, Passos-Bueno MR. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet. 1998;77(2):155\u201361.","journal-title":"Am J Med Genet"},{"issue":"1\u20132","key":"651_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","volume":"92","author":"NJ Beauchamp","year":"2007","unstructured":"Beauchamp NJ, Dalton A, Ramaswami U, et al. Glycogen storage disease type IX: high variability in clinical phenotype. Mol Genet Metab. 2007;92(1\u20132):88\u201399.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"651_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12881-019-0789-8","volume":"20","author":"J Fu","year":"2019","unstructured":"Fu J, Wang T, Xiao X. A novel PHKA2 mutation in a Chinese child with glycogen storage disease type IXa: a case report and literature review. BMC Med Genet. 2019;20(1):56.","journal-title":"BMC Med Genet"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-023-00651-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-023-00651-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-023-00651-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:01:56Z","timestamp":1690977716000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/s13039-023-00651-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s13039-023-00651-3","relation":{},"ISSN":["1755-8166"],"issn-type":[{"type":"electronic","value":"1755-8166"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee approval was obtained from the Institutional Ethics Committee of Quanzhou Women\u2019s and Children\u2019s Hospital for the commencement of this study (2020No.31). All procedures performed involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all subjects and\/or guardian(s) involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that written informed consent was signed by the patient\u2019s parents for publishing their own and their children\u2019s genetic data and relevant information, and the written informed consent is available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}